Trials / Not Yet Recruiting
Not Yet RecruitingNCT06354114
A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011
A Single-arm Open-label Phase II Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011
- Status
- Not Yet Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- CSPC Ouyi Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of this study is to evaluate the efficacy and safety in subjects with advanced breast cancer treated with SYHX2011
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SYHX2011 | IV infusion, 260 mg/m\^2 |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2024-10-31
- Completion
- 2026-12-01
- First posted
- 2024-04-09
- Last updated
- 2024-04-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06354114. Inclusion in this directory is not an endorsement.